Generics Maker Teva Pharmaceutical to Make Smaller Acquisitions, Chairman Says

Teva (TEVA), known for a series of large acquisitions that helped build its generic drug business, is now aiming mostly at smaller deals, the company’s chairman told Bloomberg.

TEVA Revenue TTM Chart

TEVA Revenue TTM data by YCharts

Deals and a reliance on generics have helped Teva grow faster than some traditional pharmaceutical makers like Novartis (NVS), Pfizer (PFE), Merck (MRK) and Sanofi (SNY).

TEVA PE Ratio TTM Chart

TEVA PE Ratio TTM data by YCharts

From the editors of YCharts, which includes the just-released YCharts Pro Platinum for professional investors.

Read more articles about: Company Analysis  

blog comments powered by Disqus
Advertisement

Search Articles

Subscribe to YCharts Analysis

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.